C-TRI wins anther patent for clarithromycin

C-TRI, an affiliated firm of Daehwa Pharm, said on September 28 it has won a Japanese patent for manufacturing clarithromycin (No. 3848837), in Japan.

Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia, skin and skin structure infections, and, in HIV and AIDS patients to pre...